Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients undergoing Anthracycline and Taxane based Adjuvant chemotherapy: Randomized, Double-blind, Placebo controlled, Phase-II Study - Efficacy of AHCC in Female Breast Cancer Patients undergoing Adjuvant chemotherapy: Randomized, Double-blind, Placebo controlled, Phase-II Study

PO Japanese Organisation for Research and Treatment of Cancer (JORTC)0 个研究点目标入组 50 人开始时间: 2014年10月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Previous chemotherapy which induce bone marrow suppression 2. Concurrent radiation or radiation within the past 4 weeks 3. Use of any mushroom based dietary supplement (7 day washout allowed) 4. Use of any other mixed herbal formula (nutritional multi vitamins are allowed) 5. Known allergy to any mushroom supplement or edible mushroom 6. Pregnant or lactating 7. Immunodeficiency disorder 8. Enrolled in other clinical trial 9. Cognitive impairment 10. Mental disorder 11. Communication difficulties due to anarthria 12. Inability to take oral medication 13. Malabsorption syndrome 14. Prior gastric resection 15. Active GI bleeding unrelated to cancer 16. The investigator's decision that a patient is inappropriate to enroll in the trial

发起方

PO Japanese Organisation for Research and Treatment of Cancer (JORTC)